<DOC>
	<DOCNO>NCT02317198</DOCNO>
	<brief_summary>A randomize controlled , open label , multicenter trial 1000 patient age 70 year old , present Non-ST-elevation acute coronary syndrome . Patients randomize either clopidogrel novel P2Y12 inhibitor ( ticagrelor prasugrel ) . Patients follow one year outcomes bleed episode require medical intervention net clinical benefit ( cause mortality , non-fatal myocardial infarction , non-fatal stroke , PLATO major minor bleeding ) .</brief_summary>
	<brief_title>Ticagrelor Prasugrel Versus Clopidogrel Elderly Patients With Acute Coronary Syndrome High Bleeding Risk : Optimization Antiplatelet Treatment High-risk Elderly</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Angina , Unstable</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Prasugrel Hydrochloride</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>At least 70 year age . Hospitalization NSTEMI UA &lt; 72 hour Contraindication P2Y12 inhibitor i.e . clopidogrel , prasugrel ticagrelor : Unable unwilling give inform consent life expectancy le one year . Having receive thrombolytic therapy within previous 24 hour . Severe renal function impairment need dialysis . Confirmed persistent severe hypertension ( Systolic Blood Pressure ( SBP ) &gt; 180 mmHg and/or Diastolic Blood Pressure ( DBP ) &gt; 110 mmHg ) randomization . At increased bleeding risk , investigator 's opinion , e.g . malignancy . Cardiogenic shock ( SBP â‰¤ 80mmHg &gt; 30 min ) IntraAortic Balloon Pump ( IABP ) time screen . History major surgery , severe trauma , fracture organ biopsy within 90 day prior randomisation . Clinically significant range value platelet count haemoglobin screening , investigator 's opinion . ACS dual antiplatelet therapy , e.g . aspirin P2Y12 inhibitor ; clopidogrel , prasugrel , ticagrelor . Patients know CYP2C19 genotype time randomization .</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Elderly</keyword>
	<keyword>P2Y12 inhibitor</keyword>
	<keyword>clopidogrel</keyword>
	<keyword>ticagrelor</keyword>
</DOC>